In addition, a previously identified ITK inhibitor (NCGC00188382) was shown to inhibit the activity of TAOK3, aurora B kinase, and cyclin-dependent kinase 7 in pancreatic cancer cells and suppress the stemness traits and growth of tumor spheroids [57]. Here, AURKB is linked to pancreatic neoplasm.